| 0 |
HEPATOBILIARY SCAN ABNORMAL |
7 |
0.0551 |
| 1 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
29 |
0.0052 |
| 2 |
SPIDER VEIN |
2 |
0.0031 |
| 3 |
CANDIDA TEST POSITIVE |
1 |
0.0024 |
| 4 |
BILIARY SEPSIS |
1 |
0.0022 |
| 5 |
VEIN DISCOLOURATION |
1 |
0.0021 |
| 6 |
PRODUCT CLOSURE ISSUE |
1 |
0.0018 |
| 7 |
PELVIC FLUID COLLECTION |
1 |
0.0014 |
| 8 |
LABORATORY TEST INTERFERENCE |
1 |
0.0013 |
| 9 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
7 |
0.0013 |
| 10 |
BILIARY DYSKINESIA |
2 |
0.0012 |
| 11 |
LACTOSE INTOLERANCE |
3 |
0.0012 |
| 12 |
IDIOSYNCRATIC DRUG REACTION |
1 |
0.0010 |
| 13 |
PALMAR ERYTHEMA |
1 |
0.0009 |
| 14 |
CONTRAST MEDIA REACTION |
2 |
0.0008 |
| 15 |
PRODUCT EXPIRATION DATE ISSUE |
1 |
0.0007 |
| 16 |
BILIARY COLIC |
2 |
0.0007 |
| 17 |
HYPOAESTHESIA FACIAL |
1 |
0.0007 |
| 18 |
DRUG EFFECT DECREASED |
35 |
0.0006 |
| 19 |
VASCULAR RUPTURE |
1 |
0.0006 |
| 20 |
PERIPHERAL ISCHAEMIA |
2 |
0.0005 |
| 21 |
REACTION TO DRUG EXCIPIENTS |
1 |
0.0005 |
| 22 |
FAECES PALE |
1 |
0.0004 |
| 23 |
GALLBLADDER DISORDER |
8 |
0.0004 |
| 24 |
CHOLECYSTITIS CHRONIC |
3 |
0.0004 |
| 25 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 26 |
STARING |
1 |
0.0004 |
| 27 |
LARYNGOSPASM |
1 |
0.0004 |
| 28 |
CHOLECYSTITIS ACUTE |
2 |
0.0004 |
| 29 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 30 |
POST PROCEDURAL COMPLICATION |
6 |
0.0003 |
| 31 |
HYPERACUSIS |
1 |
0.0003 |
| 32 |
CLAVICLE FRACTURE |
1 |
0.0003 |
| 33 |
CONCUSSION |
2 |
0.0003 |
| 34 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
11 |
0.0002 |
| 35 |
EXTRAVASATION |
1 |
0.0002 |
| 36 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
| 37 |
APHAGIA |
1 |
0.0002 |
| 38 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 39 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 40 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 41 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 42 |
INCOHERENT |
1 |
0.0002 |
| 43 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 44 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 45 |
NO ADVERSE EVENT |
24 |
0.0001 |
| 46 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 47 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 48 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 49 |
NEPHROPATHY |
1 |
0.0001 |
| 50 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 51 |
FOOT DEFORMITY |
1 |
0.0001 |
| 52 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 53 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 54 |
GASTRIC DISORDER |
3 |
0.0001 |
| 55 |
EYELID OEDEMA |
1 |
0.0001 |
| 56 |
CHOLECYSTITIS |
1 |
0.0001 |
| 57 |
ACCIDENT |
1 |
0.0001 |
| 58 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
| 59 |
PRODUCT QUALITY ISSUE |
11 |
0.0001 |
| 60 |
MYDRIASIS |
1 |
0.0001 |
| 61 |
HIATUS HERNIA |
1 |
0.0001 |
| 62 |
GASTRITIS |
2 |
0.0001 |
| 63 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 64 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 65 |
CHILLS |
7 |
0.0001 |
| 66 |
SCAR |
1 |
0.0001 |
| 67 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 68 |
PELVIC PAIN |
1 |
0.0001 |
| 69 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 70 |
CONVULSION |
3 |
0.0001 |
| 71 |
PREGNANCY |
1 |
0.0000 |
| 72 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 73 |
TOOTH LOSS |
1 |
0.0000 |
| 74 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 75 |
EATING DISORDER |
1 |
0.0000 |
| 76 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 77 |
DYSGEUSIA |
3 |
0.0000 |
| 78 |
HYPERHIDROSIS |
5 |
0.0000 |
| 79 |
MYALGIA |
6 |
0.0000 |
| 80 |
RENAL INJURY |
1 |
0.0000 |
| 81 |
EMOTIONAL DISTRESS |
4 |
0.0000 |
| 82 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 83 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 84 |
CHOLELITHIASIS |
1 |
0.0000 |
| 85 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 86 |
ABDOMINAL PAIN |
7 |
0.0000 |
| 87 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 88 |
LIP SWELLING |
1 |
0.0000 |
| 89 |
DRUG INEFFECTIVE |
38 |
0.0000 |
| 90 |
INJURY |
2 |
0.0000 |
| 91 |
SLEEP DISORDER |
2 |
0.0000 |
| 92 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 93 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 94 |
DYSKINESIA |
1 |
0.0000 |
| 95 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 96 |
URTICARIA |
4 |
0.0000 |
| 97 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 98 |
TACHYCARDIA |
2 |
0.0000 |
| 99 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 100 |
THROAT IRRITATION |
1 |
0.0000 |
| 101 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 102 |
TINNITUS |
1 |
0.0000 |
| 103 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 104 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 105 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 106 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 107 |
SYNCOPE |
2 |
0.0000 |
| 108 |
FLUSHING |
2 |
0.0000 |
| 109 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 110 |
ERYTHEMA |
4 |
0.0000 |
| 111 |
NERVOUSNESS |
1 |
0.0000 |
| 112 |
PANCREATITIS |
1 |
0.0000 |
| 113 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 114 |
TREMOR |
3 |
0.0000 |
| 115 |
MEDICATION ERROR |
1 |
0.0000 |
| 116 |
EYE PAIN |
1 |
0.0000 |
| 117 |
PYREXIA |
6 |
0.0000 |
| 118 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 119 |
PALPITATIONS |
2 |
0.0000 |
| 120 |
FEELING ABNORMAL |
4 |
0.0000 |
| 121 |
NAUSEA |
13 |
0.0000 |
| 122 |
DISCOMFORT |
1 |
0.0000 |
| 123 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 124 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 125 |
SWELLING FACE |
1 |
0.0000 |
| 126 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 127 |
RENAL FAILURE |
2 |
0.0000 |
| 128 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 129 |
VISION BLURRED |
2 |
0.0000 |
| 130 |
WEIGHT DECREASED |
4 |
0.0000 |
| 131 |
HYPERTENSION |
3 |
0.0000 |
| 132 |
ANXIETY |
4 |
0.0000 |
| 133 |
DIZZINESS |
7 |
0.0000 |
| 134 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 135 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 136 |
PAIN |
8 |
0.0000 |
| 137 |
DIARRHOEA |
8 |
0.0000 |
| 138 |
CARDIAC ARREST |
1 |
0.0000 |
| 139 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 140 |
MUSCLE SPASMS |
2 |
0.0000 |
| 141 |
CHEST PAIN |
2 |
0.0000 |
| 142 |
SWELLING |
1 |
0.0000 |
| 143 |
ASTHENIA |
4 |
0.0000 |
| 144 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 145 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 146 |
HEART RATE INCREASED |
1 |
0.0000 |
| 147 |
HYPOTENSION |
2 |
0.0000 |
| 148 |
SOMNOLENCE |
2 |
0.0000 |
| 149 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 150 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 151 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 152 |
RASH |
4 |
0.0000 |
| 153 |
MALAISE |
4 |
0.0000 |
| 154 |
SEPSIS |
1 |
0.0000 |
| 155 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 156 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 157 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 158 |
HEADACHE |
4 |
0.0000 |
| 159 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 160 |
DYSPNOEA |
3 |
0.0000 |
| 161 |
DEPRESSION |
1 |
0.0000 |
| 162 |
VOMITING |
2 |
0.0000 |
| 163 |
FATIGUE |
3 |
0.0000 |
| 164 |
COUGH |
1 |
0.0000 |
| 165 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 166 |
PRURITUS |
1 |
0.0000 |
| 167 |
OFF LABEL USE |
1 |
0.0000 |